CAR T-cell therapy (Kite Pharma/Tel Aviv Sourasky Medical Center)

N/A

Report date: 2025/03/14 16:51:09

Base Information

Drug NameCAR T-cell therapy (Kite Pharma/Tel Aviv Sourasky Medical Center)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionImmunostimulantsT lymphocytes stimulants

TargetsUpdating

Therapy Area/IndicationsLeukemiaNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesIsrael

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKite Pharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesTel-Aviv Sourasky Medical Center Kite Pharma Inc

Inactive CompaniesN/A

Active IndicationsLeukemia

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A